Agnieszka Gallagher
General Counsel presso STANDARD BIOTOOLS INC.
Patrimonio netto: 557 092 $ in data 31/03/2024
Profilo
Agnieszka Gallagher è Chief Ethics & Compliance Officer presso Alnylam Pharmaceuticals, Inc. e Secretary & Chief Compliance Officer presso ViiV Healthcare Ltd. La sig.ra Gallagher ha conseguito un diploma di laurea e una laurea presso la Rutgers State University del New Jersey.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
23/03/2023 | 90 584 ( 0.12% ) | 557 092 $ | 31/03/2024 |
Posizioni attive di Agnieszka Gallagher
Società | Posizione | Inizio |
---|---|---|
STANDARD BIOTOOLS INC. | General Counsel | - |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Compliance Officer | 01/01/2017 |
Precedenti posizioni note di Agnieszka Gallagher
Società | Posizione | Fine |
---|---|---|
ORASURE TECHNOLOGIES, INC. | Compliance Officer | 25/06/2022 |
ALNYLAM PHARMACEUTICALS, INC. | Compliance Officer | - |
Formazione di Agnieszka Gallagher
Rutgers State University of New Jersey | Graduate Degree |
Rutgers Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ORASURE TECHNOLOGIES, INC. | Health Technology |
STANDARD BIOTOOLS INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Agnieszka Gallagher